Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
- Submitting institution
-
Swansea University / Prifysgol Abertawe
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 31639
- Type
- D - Journal article
- DOI
-
10.1016/S2213-8587(17)30085-2
- Title of journal
- The Lancet Diabetes and Endocrinology
- Article number
- -
- First page
- 355
- Volume
- 5
- Issue
- 5
- ISSN
- 22138587
- Open access status
- Compliant
- Month of publication
- May
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
7
- Research group(s)
-
1 - Biomarkers and Genes
- Citation count
- 132
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -